NEWS - Porosome Therapeutics, Inc.

"State of Science at Porosome Therapeutics, Inc. 2025”, an Introduction by Guillermo Marmol, CEO. Guests in Attendance: J. P. Morgan Executives

Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena presented the Opening Ceremony and Keynote Lecture entitled: “The Porosome Secretory Nanomachine: Discovery to Therapy”, at the International Drug Discovery Science & Technology (IDDST) Congress in Kyoto, Japan

Porosome Therapeutics Unveils Groundbreaking Discovery in Alzheimer’s Disease Research and Treatment

Porosome Therapeutics, Inc. CEO and Chairman are Interviewed in Cambridge, MA

FDA Grants Orphan Drug Designation to Revolutionary Cystic Fibrosis Therapy

Porosome reconstitution therapy: A biologic rescue from cystic fibrosis (In human lung organoids and in CF mice)

State of Science at Porosome Therapeutics, Inc.

Porosome Therapeutics Inc, is proud to announce that Company Chairman Prof. Bhanu P. Jena delivered the Commencement Keynote Address to the 2024 Graduating Medical Class at Wayne State University on 6th June, 2024.

Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena presents Public Lecture entitled: “A Humbling Journey Through Science”

Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena recognized with the 2024 “Lipid Science Prize”

Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.

Discovery Underlying Porosome Therapeutics, Inc. Continues to Receive Global Recognition